Shares of Spire Inc. (NYSE:SR – Get Free Report) have been assigned an average recommendation of “Reduce” from the eight research firms that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $66.19.
A number of analysts have commented on the stock. Morgan Stanley upped their target price on shares of Spire from $70.00 to $76.00 and gave the company an “equal weight” rating in a report on Wednesday, September 25th. Wells Fargo & Company upped their target price on shares of Spire from $72.00 to $73.00 and gave the company an “equal weight” rating in a report on Wednesday, October 16th. LADENBURG THALM/SH SH cut shares of Spire from a “neutral” rating to a “sell” rating and reduced their price objective for the stock from $65.50 to $60.50 in a research note on Thursday, October 17th. Finally, Stifel Nicolaus raised their target price on shares of Spire from $64.00 to $70.00 and gave the company a “hold” rating in a research note on Thursday, August 1st.
View Our Latest Stock Analysis on SR
Insider Buying and Selling at Spire
Institutional Trading of Spire
A number of large investors have recently made changes to their positions in SR. Vanguard Group Inc. increased its stake in Spire by 1.2% in the first quarter. Vanguard Group Inc. now owns 5,626,863 shares of the utilities provider’s stock valued at $345,321,000 after purchasing an additional 65,486 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Spire by 8.3% during the second quarter. Dimensional Fund Advisors LP now owns 944,387 shares of the utilities provider’s stock worth $57,351,000 after acquiring an additional 72,119 shares during the last quarter. Victory Capital Management Inc. grew its position in shares of Spire by 11.0% during the second quarter. Victory Capital Management Inc. now owns 698,819 shares of the utilities provider’s stock worth $42,439,000 after acquiring an additional 69,020 shares during the last quarter. Thrivent Financial for Lutherans grew its position in shares of Spire by 1.7% during the second quarter. Thrivent Financial for Lutherans now owns 644,525 shares of the utilities provider’s stock worth $39,142,000 after acquiring an additional 10,562 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its holdings in shares of Spire by 0.5% during the second quarter. The Manufacturers Life Insurance Company now owns 501,852 shares of the utilities provider’s stock worth $30,477,000 after purchasing an additional 2,598 shares during the period. 87.36% of the stock is currently owned by hedge funds and other institutional investors.
Spire Stock Down 0.4 %
Shares of Spire stock opened at $62.24 on Thursday. The company has a market cap of $3.59 billion, a price-to-earnings ratio of 14.96, a price-to-earnings-growth ratio of 2.76 and a beta of 0.52. The company’s 50 day moving average is $65.57 and its 200 day moving average is $63.35. Spire has a twelve month low of $56.36 and a twelve month high of $68.02. The company has a quick ratio of 0.35, a current ratio of 0.48 and a debt-to-equity ratio of 1.11.
Spire Company Profile
Spire Inc, together with its subsidiaries, engages in the purchase, retail distribution, and sale of natural gas to residential, commercial, industrial, and other end-users of natural gas in the United States. The company operates through three segments: Gas Utility, Gas Marketing, and Midstream. It is also involved in the marketing of natural gas and related services; and transportation and storage of natural gas.
Recommended Stories
- Five stocks we like better than Spire
- What is the Shanghai Stock Exchange Composite Index?
- Intel: Is Now the Time to Be Brave?Â
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- What is the Nasdaq? Complete Overview with History
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Spire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire and related companies with MarketBeat.com's FREE daily email newsletter.